Articles by Editor

(Bloomberg) — DocuSign Inc. projected revenue that topped analysts’ estimates, in a sign of robust demand for the application that lets businesses sign documents remotely during the coronavirus pandemic.Sales in the period that ends in October will be as much as $362 million, the San Francisco-based company said Thursday in a statement. Analysts, on average, projected $336 million, according to data compiled by Bloomberg. The company raised its annual revenue to as much as $1.39 billion from an earlier expectation of $1.32 billion. Analysts were looking for $1.32 billion.DocuSign Chief Executive Officer Dan Springer has tried to integrate the e-signature …read more […]

Yahoo Finance’s Kristin Myers and Dan Howley discuss pressure on tech stocks following Apple’s touching a $2T market value. …read more […]

The appeal hearing for Amarin’s (AMRN) high triglyceride treatment Vascepa kicked off on Wednesday and ended on a negative note. The appeals court affirmed the district court’s ruling invalidating Vascepa’s patents in the US. Accordingly, shares took a merciless 37% plunge over the past two trading days.As a reminder, in March, Amarin lost a patent court case against generic drug makers, Hikma Pharmaceuticals and Dr. Reddy’s, which are seeking to sell their own versions of Vascepa.At the hearing’s conclusion, Stifel analyst Derek Archila bluntly stated, “We would not be buying shares here.”The analyst further said, “Given Vascepa’s complexity, we think …read more […]

Market’s got hit hard on Thursday as Apple led a tech selloff as investors cashed in on the months-long market rally. Portfolio Wealth Advisors President & CIO Lee Munson joins The Final Round panel to discuss what investors should look at.
…read more […]

The markets closed in the red as the market saw its largest sell off since June with the big technology names seeing a sharp drop. The Final Round panel discusses the latest. …read more […]

In this article we are going to estimate the intrinsic value of The Southern Company (NYSE:SO) by taking the forecast… …read more […]

On Thursday, Novavax published positive trial data, saying that its coronavirus vaccine candidate was ‘safe’ and ‘elected an immune response. This come as Sanofi and GlaxoSmithKline announced that they would start phase 1/2 of their adjuvanted vaccine. Yahoo Finance’s Anjalee Khemlani breaks down the latest news about the coronavirus on The Final Round. …read more […]

Kim Catechis, Martin Currie’s Head of Investment Strategy, joins Yahoo Finance’s Kristin Myers to discuss Thursday’s market sell-off, as another 881,000 Americans file for new unemployment claims, and U.S. coronavirus cases continue to climb. …read more […]

It is hard to get excited after looking at Cisco Systems’ (NASDAQ:CSCO) recent performance, when its stock has… …read more […]

…read more […]

Dr. Jennifer Peña, Former White House Medical Unit Physician for Obama, Biden, and Pence, joins Yahoo Finance’s Zack Guzman to discuss the latest coronavirus outlook as U.S. cases top 6.1 million. …read more […]